HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Metronidazole Topical Gel USP, 0.75% ("metronidazole gel").
